RANALLO, NICOLETTA
 Distribuzione geografica
Continente #
AS - Asia 1.227
NA - Nord America 510
EU - Europa 241
SA - Sud America 71
Continente sconosciuto - Info sul continente non disponibili 70
AF - Africa 20
OC - Oceania 1
Totale 2.140
Nazione #
US - Stati Uniti d'America 486
CN - Cina 335
SG - Singapore 277
VN - Vietnam 212
BD - Bangladesh 138
IT - Italia 109
HK - Hong Kong 102
KR - Corea 59
BR - Brasile 52
IN - India 37
FR - Francia 36
NL - Olanda 20
FI - Finlandia 19
JP - Giappone 19
DE - Germania 15
CA - Canada 12
PH - Filippine 11
PL - Polonia 11
AR - Argentina 9
ID - Indonesia 8
GB - Regno Unito 7
MX - Messico 6
BE - Belgio 5
CI - Costa d'Avorio 5
IQ - Iraq 5
TH - Thailandia 5
CL - Cile 4
CO - Colombia 4
PK - Pakistan 4
ZA - Sudafrica 4
RU - Federazione Russa 3
SA - Arabia Saudita 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
UA - Ucraina 3
AT - Austria 2
BG - Bulgaria 2
GH - Ghana 2
IE - Irlanda 2
MY - Malesia 2
SE - Svezia 2
SV - El Salvador 2
TJ - Tagikistan 2
TR - Turchia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
GA - Gabon 1
GP - Guadalupe 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LT - Lituania 1
LY - Libia 1
MU - Mauritius 1
MW - Malawi 1
PR - Porto Rico 1
SN - Senegal 1
VE - Venezuela 1
YE - Yemen 1
Totale 2.071
Città #
Singapore 196
Hefei 166
San Jose 97
Hong Kong 94
Ashburn 66
Ho Chi Minh City 64
Council Bluffs 60
Seoul 55
Hanoi 41
Los Angeles 33
Lauterbourg 21
Bengaluru 19
Beijing 18
Tokyo 16
Buffalo 13
Helsinki 13
New York 13
Santa Clara 13
Dallas 12
Haiphong 12
Da Nang 9
Guangzhou 9
Naples 9
São Paulo 9
Boardman 8
Bologna 7
Rome 7
Warsaw 7
Chicago 6
Lappeenranta 6
Phoenix 6
Redondo Beach 6
Abidjan 5
Brussels 5
Frankfurt am Main 5
Frosolone 5
Mexico City 5
Biên Hòa 4
Columbus 4
Nuremberg 4
Salt Lake City 4
Shenzhen 4
Tongling 4
Xi'an 4
Zhoukou 4
Amsterdam 3
Can Tho 3
Changsha 3
Milan 3
Milwaukee 3
Modena 3
Nha Trang 3
Piscataway 3
San Francisco 3
Senigallia 3
Tianjin 3
Trieste 3
Điện Bàn 3
Acalanes Ridge 2
Accra 2
Alhambra 2
Atlanta 2
Baghdad 2
Bangkok 2
Brooklyn 2
Bình Dương 2
Bình Phước 2
Cagliari 2
Calgary 2
Contagem 2
Criciúma 2
Detroit 2
Dublin 2
Dushanbe 2
Düsseldorf 2
Hangzhou 2
Jakarta 2
Johannesburg 2
Kansas City 2
Modica 2
Montreal 2
New Delhi 2
Orem 2
Pasadena 2
Pereira 2
Philadelphia 2
Quận Tân Phú 2
Salvador 2
San Salvador 2
Santiago 2
Santo André 2
Shanghai 2
Sofia 2
Stockholm 2
Toronto 2
Turin 2
Tân Tiến 2
Volta Redonda 2
Wroclaw 2
Ân Thi 2
Totale 1.291
Nome #
Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin 197
HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors 194
177Lu-DOTATATE Efficacy and Safety in Functioning Neuroendocrine Tumors: A Joint Analysis of Phase II Prospective Clinical Trials 172
Lipids and adipocytes involvement in tumor progression with a focus on obesity and diet 159
First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax) 156
Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data Analysis 150
Potential benefit of β-glucans as adjuvant therapy in immuno-oncology: a review 108
Treatments and Outcomes in Neuroendocrine Patients Treated with Long-Acting Somatostatin Analogues: An Italian Real-World Propensity Score-Matched Cohort Study 96
Cancer patient perspective in the arena of COVID-19 pandemic 91
Scientia Potentia Est: How the Italian World of Oncology Changes in the COVID-19 Pandemic 87
Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series 84
Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up 82
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas 82
The gustave roussy immune (Grim)-score variation is an early-on-treatment biomarker of outcome in advanced non-small cell lung cancer (nsclc) patients treated with first-line pembrolizumab 81
Delta-like ligand 3 (DLL3): an attractive actionable target in tumors with neuroendocrine origin 79
Lu-PRRT Used More Intensively on Advanced Gastro-Entero-Pancreatic and Lung Neuroendocrine Neoplasms: Preliminary Results on Toxicity from a Randomized Study 70
Bone metastases from neuroendocrine neoplasms: Results of an Italian nationwide survey of natural history and management 51
COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study 48
Tailored therapy in patients treated with fluoropyrimidines: focus on the role of dihydropyrimidine dehydrogenase 43
Theragnostic in neuroendocrine tumors 43
Gender Differences and Outcomes in Melanoma Patients 39
Potential immune‑related adverse events during dabrafenib and trametinib treatment: A case series of patients with BRAF V600E melanoma 27
null 1
Totale 2.140
Categoria #
all - tutte 4.682
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.682


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20232 0 0 0 0 0 0 0 0 0 0 1 1
2023/202424 0 2 0 1 0 1 0 4 5 2 7 2
2024/2025203 6 8 8 4 11 4 5 8 34 22 29 64
2025/20261.807 155 187 142 142 72 41 278 115 277 107 163 128
2026/2027104 40 64 0 0 0 0 0 0 0 0 0 0
Totale 2.140